Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Observational, Retrospective Study of Eribulin in Advanced Breast Cancer

NCT04541420 is registered in ClinicalTrials.gov with Fudan University as lead sponsor.

NCT NCT04541420
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04541420 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Observational, Retrospective Study of Eribulin in Advanced Breast Cancer
Lead sponsor
Fudan University
Phase
Observational
Overall status
Completed
Start date
December 15, 2019
Completion date
December 20, 2020
Enrollment
208 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer